The spectrum of tremor among carriers of the FMR1 premutation with or without the fragile X-associated tremor/ataxia syndrome (FXTAS)

Tsviya Fay-Karmon*, Sharon Hassin-Baer

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

11 Scopus citations

Abstract

Fragile X-associated tremor/ataxia syndrome (FXTAS) is a genetically determined neurodegenerative disease which is caused by a 55–200 expansion of CGG repeat element in the promoter region of the fragile X mental retardation 1 (FMR1) gene. The major clinical manifestations are tremor and cerebellar ataxia. Different types of tremor are described in patients with FXTAS: essential tremor-like, rest tremor and cerebellar tremor, and the different tremor types may coexist. There is no effective disease modifying therapy for FXTAS, but troublesome tremor may be treated by pharmacological and surgical approaches used for other more common disorders such as essential tremor and Parkinson's disease.

Original languageEnglish
Pages (from-to)32-38
Number of pages7
JournalParkinsonism and Related Disorders
Volume65
DOIs
StatePublished - Aug 2019

Funding

FundersFunder number
Azrieli Foundation

    Keywords

    • FMR1 gene
    • FXTAS
    • Fragile X-associated tremor/ataxia syndrome
    • Tremor

    Fingerprint

    Dive into the research topics of 'The spectrum of tremor among carriers of the FMR1 premutation with or without the fragile X-associated tremor/ataxia syndrome (FXTAS)'. Together they form a unique fingerprint.

    Cite this